• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>CNS spectrums >Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11
【24h】

Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11

机译：神经发育障碍（ASD和ADHD）：DSM-5，ICD-10和ICD-11

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Neurodevelopmental disorders, specifically autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) have undergone considerable diagnostic evolution in the past decade. In the United States, the current system in place is the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), whereas worldwide, the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) serves as a general medical system. This review will examine the differences in neurodevelopmental disorders between these two systems. First, we will review the important revisions made from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) to the DSM-5, with respect to ASD and ADHD. Next, we will cover the similarities and differences between ASD and ADHD classification in the DSM-5 and the ICD-10, and how these differences may have an effect on neurodevelopmental disorder diagnostics and classification. By examining the changes made for the DSM-5 in 2013, and critiquing the current ICD-10 system, we can help to anticipate and advise on the upcoming ICD-11, due to come online in 2017. Overall, this review serves to highlight the importance of progress towards complementary diagnostic classification systems, keeping in mind the difference in tradition and purpose of the DSM and the ICD, and that these systems are dynamic and changing as more is learned about neurodevelopmental disorders and their underlying etiology. Finally this review will discuss alternative diagnostic approaches, such as the Research Domain Criteria (RDoC) initiative, which links symptom domains to underlying biological and neurological mechanisms. The incorporation of new diagnostic directions could have a great effect on treatment development and insurance coverage for neurodevelopmental disorders worldwide.
机译：在过去的十年中，神经发育障碍，特别是自闭症谱系障碍（ASD）和注意力不足/多动症（ADHD）经历了可观的诊断发展。在美国，当前使用的系统是《精神疾病诊断和统计手册》第五版（DSM-5），而在世界范围内，《疾病和相关健康问题国际统计分类》第十次修订版（ICD-10）作为一般医疗系统。这篇综述将研究这两个系统之间神经发育障碍的差异。首先，我们将回顾《精神障碍诊断和统计手册》第四版，文本修订版（DSM-IV-TR）对DSM-5进行的有关ASD和ADHD的重要修订。接下来，我们将介绍DSM-5和ICD-10中ASD和ADHD分类之间的异同，以及这些差异如何影响神经发育障碍的诊断和分类。通过检查2013年对DSM-5所做的更改，并评估当前的ICD-10系统，我们可以帮助预测将于2017年投入使用的即将到来的ICD-11。牢记DSM和ICD在传统和目的上的差异，并朝着互补的诊断分类系统发展的重要性，并且随着对神经发育障碍及其病因的了解越来越多，这些系统是动态的并且正在发生变化。最后，本文将讨论其他诊断方法，例如“研究领域标准（RDoC）”倡议，该倡议将症状领域与潜在的生物学和神经学机制联系起来。纳入新的诊断方向可能会对全球神经发育疾病的治疗发展和保险范围产生重大影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号